Cholangitis: Clinical Trials

2 trials for Cholangitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 2

Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antibiotics to Decrease Post ERCP Cholangitis
Ceftriaxone, Levofloxacin - Cholangitis
Phase 4UnknownUniversity of Southern California2002017-03-292023-03-06
Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients
Vancomycin, Placebo - Primary Sclerosing Cholangitis
Phase 4UnknownTehran University of Medical Sciences302015-09-012015-11-16

Narrower conditions

Cholangitis, Sclerosing (1)

Broader conditions

Bile Duct Diseases (2)  ·  Biliary Tract Diseases (2)  ·  Digestive System Diseases (2)

Interventions

Ceftriaxone (1)  ·  Levofloxacin (1)  ·  Vancomycin (1)

Sponsors

Tehran University of Medical Sciences (1)  ·  University of Southern California (1)

Countries

Iran (1)  ·  United States (1)

Top investigators

James Buxbaum (1)  ·  Mohammad Kazem NouriTaromlou, M.D. (1)  ·  Mohsen Nasiri Toosi, Professor (1)  ·  Naser Ebrahimi Daryani, Professor (1)  ·  Sanam Javidanbardan, M.D. (1)  ·  Shahab Rahimpour, fellowship (1)  ·  Zahra Azizi, M.D. (1)

Results publications

PMID 15557948, PMID 17509029, PMID 17696583, PMID 18061594, PMID 18462108, PMID 19238021, PMID 19286178, PMID 20927758, PMID 21692712, PMID 21835401, PMID 2209498, PMID 23307001, PMID 25442089, PMID 8779455